reata pharmaceuticals inc stock price

RETA Reata the Company or we a clinical-stage biopharmaceutical company today announced that. The firm has a 50-day simple moving.


Reata Pharmaceuticals Nasdaqgm Reta Share Price News Analysis Simply Wall St

RETA Reata Pharmaceuticals Inc - Ordinary Shares - Class A Stock Price and Discussion Stocktwits.

. The stock price appears overvalued given the poor outlook for the companys treatments. 102 rows Discover historical prices for RETA stock on Yahoo Finance. The share prices change because of supply and demand.

Reata Pharmaceuticals Inc. Find out more here. View the latest Reata Pharmaceuticals Inc.

Cl A RETA stock price news historical charts analyst ratings and financial information from WSJ. Stock analysis for Reata Pharmaceuticals Inc RETANASDAQ GM including stock price stock chart company news key statistics fundamentals and company profile. Get the latest Reata Pharmaceuticals Inc RETA real-time quote historical performance charts and other financial information to help you make more informed trading and investment.

Cl A RETA stock price news historical charts analyst ratings and financial information from WSJ. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. Reatas development programs have created a robust pipeline of drug candidates for the treatment of serious life-threatening diseases.

Their RETA share price forecasts range from 2700 to 11200. Get the latest Reata Pharmaceuticals Inc RETA detailed stock quotes stock data Real-Time ECN charts. Not an offer or recommendation by Stocktwits.

RETA stock quote history news and other vital information to help you with your stock trading and investing. 7 equities research analysts have issued 12 month target prices for Reata Pharmaceuticals stock. Investors may have less confidence in Reata Pharmaceuticals Inc.

Reata Pharmaceuticals has a 52 week low of 1847 and a 52 week high of 11480. Investment amount Start date. Class A Common Stock RETA Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets.

Get the latest Reata Pharmaceuticals Inc. RETA stock price news buy or sell recommendation and investing advice from Wall Street professionals. A high-level overview of Reata Pharmaceuticals Inc.

NASDAQRETA may have lost US207m in value but insiders who invested last year have seen gains of around US44k to date. Find the latest Reata Pharmaceuticals Inc. Get Reata Pharmaceuticals Inc RETANASDAQ real-time stock quotes news price and financial information from CNBC.

The companys Stock price change every day as a result of market forces. RETA Reata the Company or we a clinical-stage biopharmaceutical company today announced that abstracts highlighting clinical. RETA stock opened at 3466 on Wednesday.

View the latest Reata Pharmaceuticals Inc. View Reata Pharmaceuticals Inc RETA investment stock information. PLANO Texas September 06 2022--Reata Pharmaceuticals Inc.


Reata Pharmaceuticals Inc Trade Ideas Nasdaq Reta Tradingview


Reta Reata Pharmaceuticals Inc Cl A Stock Overview U S Nasdaq Barron S


Strength Seen In Reata Pharmaceuticals Inc Reta Can Its 3 Jump Turn Into More Strength


We Think Reata Pharmaceuticals Nasdaq Reta Can Afford To Drive Business Growth Simply Wall St News


Reata Pharmaceuticals Inc Formdefa14a Reata Pharmaceuticals Nasdaq Reta Benzinga


Reata Reta Falls On Negative Advisory Committee Outcome Nasdaq


Reta Stock Price Reata Pharmaceuticals Inc Rallies Over 30 After Phase 3 Progress Earnings


Reta Reata Pharmaceuticals Inc Cl A Stock Overview U S Nasdaq Barron S


Reata Pharma Announces 350 Million Strategic Investment From Blackstone Life Sciences


Reata Pharmaceuticals Inc 2021 Q2 Results Earnings Call Presentation Nasdaq Reta Seeking Alpha


Reata Pharmaceuticals Inc Reta Stock Price Quote News Stock Analysis


Buy Reata Pharmaceuticals Stock Reta Stock Price Today News Public Com


Reata Pharmaceuticals Inc Reta Stock Price Quote News Stock Analysis


Reata Pharmaceuticals Inc Reta Stock 10 Year History


Why Reata Pharmaceuticals Nose Dived On Monday The Motley Fool


Reata Reta Friedreich S Ataxia Nda Gets Priority Review Nasdaq


Reata Pharmaceuticals Inc Reta Stock 52 Week High Low


Reata Pharmaceuticals Inc Reta Stock 52 Week High Low


Reta Reata Pharmaceuticals Inc Cl A Stock Overview U S Nasdaq Barron S

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel